• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    26 Stocks Moving in Monday's Pre-Market Session

    4/4/22 6:32:54 AM ET
    $ABIO
    $BILI
    $BLBX
    $BRQS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    EDP Services
    Technology
    Get the next $ABIO alert in real time by email

    Gainers

    • SPI Energy Co., Ltd. (NASDAQ:SPI) rose 36.3% to $3.87 in pre-market trading after reporting record revenue of $162 million for 2021.
    • Twitter, Inc. (NYSE:TWTR) rose 25.7% to $49.44 in pre-market trading after Elon Musk disclosed a 9.2% passive stake in the company.
    • Iron Spark I Inc. (NASDAQ:ISAA) rose 18% to $11.80 in pre-market trading. Hypebeast will list shares in U.S. through merger with Iron Spark I, the Wall Street Journal reported.
    • Context Therapeutics Inc. (NASDAQ:CNTX) shares rose 17.9% to $2.83 in pre-market trading after jumping over 10% on Friday. Context Therapeutics recently posted FY21 net loss of $10.5 million.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) rose 15.9% to $0.2434 in pre-market trading. TDR Capital reported a new stake of 9.9% in Borqs Technologies.
    • Yumanity Therapeutics, Inc. (NASDAQ:YMTX) rose 13.1% to $1.73 in pre-market trading. Yumanity Therapeutics recently posted a FY21 loss of $3.84 per share.
    • Infobird Co., Ltd (NASDAQ:IFBD) shares rose 12.7% to $0.7899 in pre-market trading. Infobird recently announced receipt of delinquency notification letter from Nasdaq.
    • TMC the metals company Inc. (NASDAQ:TMC) rose 11.4% to $2.73 in pre-market trading.
    • Bilibili Inc. (NASDAQ:BILI) rose 10.8% to $30.60 in pre-market trading after surging 8% on Friday.
    • 17 Education & Technology Group Inc. (NASDAQ:YQ) rose 10.6% to $3.02 in pre-market trading.
    • Enservco Corporation (NYSE:ENSV) rose 10% to $2.74 in pre-market trading after declining around 8% on Friday.
    • Lizhi Inc. (NASDAQ:LIZI) rose 9.6% to $1.60.
    • Expion360 Inc. (NASDAQ:XPON) rose 9% to $8.64 in pre-market trading. The company recently priced its IPO at $7 per share.
    • Siyata Mobile Inc. (NASDAQ:SYTA) rose 8.5% to $1.27 in pre-market trading after declining 6% on Friday.
    • Reed's, Inc. (NASDAQ:REED) rose 7.4% to $0.27 in pre-market trading after dipping 16% on Friday. Reed's recently reported worse-than-expected Q4 EPS and sales results.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Iveda Solutions, Inc. (NASDAQ:IVDA) shares fell 13.7% to $3.25 in pre-market trading after climbing around 12% on Friday.
    • Liquid Media Group Ltd. (NASDAQ:YVR) shares fell 12.2% to $0.70 in pre-market trading after jumping 12% on Friday.
    • Weidai Ltd. (NYSE:WEI) fell 11.9% to $1.26 in pre-market trading after jumping 29% on Friday.
    • Curis, Inc. (NASDAQ:CRIS) fell 9.5% to $2.20 in pre-market trading.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares fell 9.4% to $0.6067 in pre-market trading. ThermoGenesis recently said FY21 sales results were down from last year.
    • Reed's, Inc. (NYSE:REED) fell 9.2% to $0.2730 in pre-market trading as the company reported fourth-quarter revenue growth of 20% year-over-year to $12.8 million, missing the consensus of $13.02 million.
    • Blackboxstocks Inc. (NASDAQ:BLBX) fell 9.1% to $2.91 in pre-market trading. Blackboxstocks shares surged 19% on Friday after the company reported better-than-expected Q4 sales results.
    • QualTek Services Inc. (NASDAQ:QTEK) fell 7.8% to $2.58 in pre-market trading. QualTek Services posted FY21 net loss from continuing operations of $49.1 million.
    • Hudson Capital Inc. (NASDAQ:HUSN) shares fell 7.2% to $2.44 in pre-market trading. Hudson Capital shares jumped 36% on Friday after the company announced it sold its wholly-owned subsidiary, Hong Kong Internet Financial Services, to private investors.
    • Ocugen, Inc. (NASDAQ:OCGN) fell 7% to $3.07 in pre-market trading.
    • ARCA biopharma, Inc. (NASDAQ:ABIO) fell 6.8% to $2.05 in pre-market trading. ARCA Biopharma recently reported the results from its Phase 2 trial of ASPEN-COVID did not meet the primary endpoint.
    Get the next $ABIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABIO
    $BILI
    $BLBX
    $BRQS

    CompanyDatePrice TargetRatingAnalyst
    Bilibili Inc.
    $BILI
    10/14/2025$36.03Outperform
    Macquarie
    Context Therapeutics Inc.
    $CNTX
    9/18/2025$5.00Buy
    Guggenheim
    Bilibili Inc.
    $BILI
    7/28/2025$24.00Overweight → Neutral
    Analyst
    Bilibili Inc.
    $BILI
    7/8/2025$28.00Outperform
    Bernstein
    TMC the metals company Inc.
    $TMC
    6/25/2025$11.00Neutral → Outperform
    Wedbush
    Bilibili Inc.
    $BILI
    5/21/2025$22.50Hold → Buy
    HSBC Securities
    TMC the metals company Inc.
    $TMC
    5/20/2025$5.50Buy
    H.C. Wainwright
    Curis Inc.
    $CRIS
    5/19/2025$17.00Buy
    H.C. Wainwright
    More analyst ratings

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Bilibili with a new price target

    Macquarie initiated coverage of Bilibili with a rating of Outperform and set a new price target of $36.03

    10/14/25 8:47:22 AM ET
    $BILI
    EDP Services
    Technology

    Guggenheim initiated coverage on Context Therapeutics with a new price target

    Guggenheim initiated coverage of Context Therapeutics with a rating of Buy and set a new price target of $5.00

    9/18/25 8:39:06 AM ET
    $CNTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bilibili downgraded by Analyst with a new price target

    Analyst downgraded Bilibili from Overweight to Neutral and set a new price target of $24.00

    7/28/25 8:33:10 AM ET
    $BILI
    EDP Services
    Technology

    $ABIO
    $BILI
    $BLBX
    $BRQS
    SEC Filings

    View All

    SEC Form EFFECT filed by Iveda Solutions Inc.

    EFFECT - Iveda Solutions, Inc. (0001397183) (Filer)

    2/10/26 12:15:29 AM ET
    $IVDA
    Computer Software: Prepackaged Software
    Technology

    SEC Form PRE 14A filed by Curis Inc.

    PRE 14A - CURIS INC (0001108205) (Filer)

    2/9/26 4:55:02 PM ET
    $CRIS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Curis Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - CURIS INC (0001108205) (Filer)

    2/9/26 4:53:58 PM ET
    $CRIS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Era Regenerative Medicine Ltd bought 1,075,269 shares (SEC Form 4)

    4 - REED'S, INC. (0001140215) (Issuer)

    6/11/25 4:36:43 PM ET
    $REED

    Chief Executive Officer Lehr Martin A. bought $70,080 worth of shares (100,000 units at $0.70) (SEC Form 4)

    4 - Context Therapeutics Inc. (0001842952) (Issuer)

    6/10/25 5:26:21 PM ET
    $CNTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer, Corp. Sec Levit Alex C. bought $11,520 worth of shares (20,000 units at $0.58), increasing direct ownership by 222% to 29,000 units (SEC Form 4)

    4 - Context Therapeutics Inc. (0001842952) (Issuer)

    6/10/25 5:23:47 PM ET
    $CNTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Shesky Craig exercised 63,204 shares at a strike of $0.65, increasing direct ownership by 6% to 1,208,921 units (SEC Form 4)

    4 - TMC the metals Co Inc. (0001798562) (Issuer)

    2/10/26 7:44:23 PM ET
    $TMC
    Metal Mining
    Basic Materials

    Director Karkar Andrei exercised 31,602 shares at a strike of $0.65, increasing direct ownership by 8% to 425,611 units (SEC Form 4)

    4 - TMC the metals Co Inc. (0001798562) (Issuer)

    2/10/26 7:42:59 PM ET
    $TMC
    Metal Mining
    Basic Materials

    Director Madsbjerg Christian exercised 43,180 shares at a strike of $0.62, increasing direct ownership by 13% to 374,800 units (SEC Form 4)

    4 - TMC the metals Co Inc. (0001798562) (Issuer)

    2/10/26 7:42:02 PM ET
    $TMC
    Metal Mining
    Basic Materials

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Iveda Establishes European Operations Center in Madrid

    Expansion positions Iveda to meet accelerating European demand for secure, AI-enhanced smart city deployments Iveda® (NASDAQ:IVDA), a global leader in AI-driven video surveillance and smart city technologies, today announced the launch of its European operations with the opening of Iveda Spain in Madrid. This milestone establishes Iveda's first European hub––alongside offices in the U.S., Taiwan, Philippines, and Egypt––and reflects growing regional demand for trusted, government-grade AI solutions to modernize public safety and critical infrastructure. The expansion comes in direct response to rising industry demand for in-region deployment, field trials, and engagements with European

    2/10/26 8:00:00 AM ET
    $IVDA
    Computer Software: Prepackaged Software
    Technology

    Iveda Announces Pricing of $2 Million Public Offering

    MESA, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Iveda® (NASDAQ:IVDA), the global leader in AI video surveillance and smart city solutions, today announced the pricing of a public offering of 5,714,286 shares of its common stock (or pre-funded warrants in lieu thereof) and series X warrants to purchase up to 11,428,572 shares of its common stock, at a combined public offering price of $0.35 per share (or pre-funded warrant in lieu thereof) and accompanying series X warrants. The series X warrants will have an exercise price of $0.35 per share, will be exercisable immediately upon issuance and will expire two years from the date of issuance. The closing of the offering is expected to occur on

    2/9/26 8:23:00 PM ET
    $IVDA
    Computer Software: Prepackaged Software
    Technology

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Financials

    Live finance-specific insights

    View All

    Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data

    MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast with KOLs and Ocugen executive leadership to discuss data from the first half of patients completing one year since treatment in the OCU410 Phase 2 ArMaDa clinical trial at 8:30 a.m. ET on Thursday, January 15, 2026. Study investigators leading the webcast include: Arshad M. Khanani, MD, MA, FASRS, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates and Clinical Professor at the University of Nevada, Reno School

    1/13/26 7:00:00 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    17 Education & Technology Group Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 10, 2025 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ:YQ) ("17EdTech" or the "Company"), a leading education technology company in China, today announced its unaudited financial results for the third quarter of 2025. Third Quarter 2025 Highlights1 Net revenues were RMB20.0 million (US$2.8 million), compared with net revenues of RMB59.6 million in the third quarter of 2024.Gross margin was 51.2%, compared with 60.9% in the third quarter of 2024.Net loss was RMB44.5 million (US$6.3 million), compared with net loss of RMB17.4 million in the third quarter of 2024.Net loss as a percentage of net revenues was negative 222.5% in the third quarter of 2025, compa

    12/9/25 5:00:00 PM ET
    $YQ
    Other Consumer Services
    Real Estate

    17 Education & Technology Group Inc. to Report Third Quarter 2025 Unaudited Financial Results on December 09, 2025

    BEIJING, Dec. 03, 2025 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ:YQ) ("17EdTech" or the "Company"), a leading education technology company in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025, on December 09, 2025, after the close of U.S. markets. The Company's management will hold an earnings conference call on Tuesday, December 09, 2025 at 8:00 p.m. U.S. Eastern Time (Wednesday, December 10, 2025 at 9:00 a.m. Beijing time). Please note that all participants will need to preregister online prior to the call to receive the dial-in details. Conference Call Preregistration Please note that all

    12/3/25 6:00:00 AM ET
    $YQ
    Other Consumer Services
    Real Estate

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Leadership Updates

    Live Leadership Updates

    View All

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer

    MALVERN, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the appointment of Rita Johnson-Greene as Chief Financial Officer (CFO). "Mrs. Johnson-Greene's diverse background across a variety of strategic roles at organizations representing many facets of the industry make her well-suited to serve as Ocugen's CFO," said Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen. "We look forward to her leadership as we enter into a transformative time at Ocugen, beginning with the submission of the first of three Biologics License Applications (BLAs) this

    2/9/26 7:02:00 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Reed's, Inc. Announces Appointment of Neal Cohane as Chief Operating Officer

    NORWALK, Conn., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE:REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Neal Cohane as Chief Operating Officer, effective January 5, 2026. Mr. Cohane brings decades of leadership experience across the beverage industry and a proven track record of building high-performing commercial organizations, scaling national distribution, and driving sustainable growth for consumer brands. Most recently, he served as Chief Sales Officer at Eastroc Beverages and previously founded Rootstock Brands, Inc., where he advised beverage companies on go-to-mar

    12/29/25 4:30:00 PM ET
    $REED

    $ABIO
    $BILI
    $BLBX
    $BRQS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/4/24 6:11:30 AM ET
    $REED